Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis
Bhatia, Neal, Heim, Jayme, Schenkel, Brad, Vasquez, J. Gabriel
Published in The Journal of dermatological treatment (31.12.2023)
Published in The Journal of dermatological treatment (31.12.2023)
Get full text
Journal Article
Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting
Bhatia, Neal, Heim, Jayme, Vasquez, J Gabriel, Bhutani, Tina, Schenkel, Brad, Gogineni, Ranga, Koo, John
Published in The Journal of dermatological treatment (01.12.2024)
Published in The Journal of dermatological treatment (01.12.2024)
Get full text
Journal Article
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
Bhutani, Tina, Koo, John, Heim, Jayme, Bhatia, Neal, Mathew, Jacob, Ferro, Thomas, Vasquez, J. Gabriel
Published in Dermatology and therapy (01.04.2024)
Published in Dermatology and therapy (01.04.2024)
Get full text
Journal Article
Neocortical and Thalamic Spread of Amygdala Kindled Seizures
Blumenfeld, Hal, Rivera, Maritza, Vasquez, J. Gabriel, Shah, Akash, Ismail, Dina, Enev, Miro, Zaveri, Hitten P.
Published in Epilepsia (Copenhagen) (01.02.2007)
Published in Epilepsia (Copenhagen) (01.02.2007)
Get full text
Journal Article
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis: Week 28 Interim Analysis of a Phase 4 Study
Heim, Jayme, Vasquez, J Gabriel, Schenkel, Brad, Bhatia, Neal
Published in Journal of drugs in dermatology (01.08.2023)
Published in Journal of drugs in dermatology (01.08.2023)
Get more information
Journal Article
Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque Psoriasis
Heim, Jayme, Vasquez, J Gabriel, Bhutani, Tina, Koo, John, Mathew, Jacob, Gogineni, Ranga, Ferro, Thomas, Bhatia, Neal
Published in Journal of drugs in dermatology (01.08.2024)
Published in Journal of drugs in dermatology (01.08.2024)
Get more information
Journal Article
Alteration of Neuropilin‑1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth
Painter, Chelsea D., Sankaranarayanan, Nehru Viji, Nagarajan, Balaji, Mandel Clausen, Thomas, West, Alan M.V., Setiawan, Nicollette J., Park, Jeeyoung, Porell, Ryan N., Bartels, Phillip L., Sandoval, Daniel R., Vasquez, Gabriel J., Chute, John P., Godula, Kamil, Vander Kooi, Craig W., Gordts, Philip L.S.M., Corbett, Kevin D., Termini, Christina M., Desai, Umesh R., Esko, Jeffrey D.
Published in ACS chemical biology (16.08.2024)
Published in ACS chemical biology (16.08.2024)
Get full text
Journal Article
42293 Real-world effectiveness of tildrakizumab in a Phase 4 study in patients with moderate-to- severe plaque psoriasis
Bhatia, Neal, Vasquez, J Gabriel, Schenkel, Brad, Rozzo, Stephen J., Heim, Jayme
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
42290 Patients’ quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis
Heim, Jayme, Vasquez, J Gabriel, Rozzo, Stephen J., Schenkel, Brad, Bhatia, Neal
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
42281 Patient satisfaction with tildrakizumab treatment in a Phase 4 real-world study of tildrakizumab in patients with moderate-to-severe psoriasis
Bhatia, MD, Neal, Vasquez, J Gabriel, Schenkel, Brad, Rozzo, Stephen J., Heim, Jayme
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
33129 Real-world effectiveness and safety of tildrakizumab in patients with moderate to severe plaque psoriasis: Week 28 interim analysis of a phase 4 study
Bhatia, Neal, Heim, Jayme, Torres, Monique, Beute, Paulita, Rozzo, Stephen J., Vasquez, J. Gabriel
Published in Journal of the American Academy of Dermatology (01.09.2022)
Published in Journal of the American Academy of Dermatology (01.09.2022)
Get full text
Journal Article
33133 A phase 4, real-world study of tildrakizumab in moderate to severe psoriasis: Week 28 interim analysis
Heim, Jayme, Vasquez, J. Gabriel, Beute, Paulita, Torres, Monique, Rozzo, Stephen J., Bhatia, Neal
Published in Journal of the American Academy of Dermatology (01.09.2022)
Published in Journal of the American Academy of Dermatology (01.09.2022)
Get full text
Journal Article
Patients’ quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis
Heim, Jayme, Vasquez, J Gabriel, Schenkel, Brad, Bhatia, Neal
Published in Skin (Milwood, N.Y.) (13.03.2023)
Published in Skin (Milwood, N.Y.) (13.03.2023)
Get full text
Journal Article